CYP3A5*3 Genotype Associated With Intrasubject Pharmacokinetic Variation Toward Tacrolimus in Bioequivalence Study-Reference-Cited by-同舟云学术

CYP3A5*3 Genotype Associated With Intrasubject Pharmacokinetic Variation Toward Tacrolimus in Bioequivalence Study

Published:2010-02 Issue:1 Volume:32 Page:67-72
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Yong Chung Jae,Jung Lee Yoon,Bok Jang Seong,Ahyoung Lim Lay,Soo Park Min,Hwan Kim Kyung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studies.;Hauschke;Int J Clin Pharmacol Ther,1994

2. Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applications.;Davit;AAPS J,2008

3. Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design.;Bekersky;J Clin Pharmacol,1999

4. Genetic contribution to variable human CYP3A-mediated metabolism.;Lamba;Adv Drug Deliv Rev,2002

5. Tacrolimus: a new immunosuppressive agent.;Kelly;Am J Health Syst Pharm,1995

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrapatient Variability (IPV) and the Blood Concentration Normalized by the Dose (C/D Ratio) of Tacrolimus—Their Correlations and Effects on Long-Term Renal Allograft Function;Biomedicines;2022-11-08

2. Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-07

3. Pharmacokinetics of a Fixed‐Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate Components;Clinical Pharmacology in Drug Development;2021-06-22

4. Pharmacogenetic perspectives in improving pharmacokinetic profiles for efficient bioequivalence trials with highly variable drugs: a review;International Journal of Pharmacokinetics;2021-03

5. CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population;South African Medical Journal;2020-01-29